SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-19-038093
Filing Date
2019-06-19
Accepted
2019-06-19 17:48:33
Documents
1
Period of Report
2017-11-22

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4686
  Complete submission text file 0001209191-19-038093.txt   6101
Mailing Address P.O. BOX 7338 BERKELEY CA 94707
Business Address
Alafi Christopher D (Reporting) CIK: 0001299430 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36274 | Film No.: 19906977

Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Issuer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences